Andere talen Q BioMed Inc.

Aandelen

QBIO

US74736N1054

Beurs gesloten - OTC Markets Andere beurzen 20:32:26 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0002 ^USD	+100,00%		0,00%	-50,00%

2023	Q BioMed Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 28 februari 2023	CI
2023	Q BioMed Inc. meldt winstresultaten voor het volledige jaar eindigend op 30 november 2022	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Q BioMed Inc. Provides Update to Shareholders	23-06-23
Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	16-06-23
Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022	26-05-23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe	17-04-23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe	14-04-23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office	13-02-23
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office	10-02-23
Q BioMed Inc.'s Chemotherapeutic Uttroside B Receives Notice of Allowance for Patent from United States Patent Office	10-02-23
Q BIOMED INC. : Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	18-11-22
Q BIOMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)	03-11-22
Q BioMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	03-11-22
Q BIOMED PROVIDES SHAREHOLDER UPDATE	11-10-22
Q BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKER	27-09-22
Q BioMed Inc. Announces Issuance of Patent for Groundbreaking Gdf15 Biomarker	27-09-22
Q BioMed Inc. Provides Update to Shareholders	29-07-22
Q BioMed Inc. Reports Second Quarter Revenues in 2022	29-07-22
Q BioMed : Quarterly Report for Quarter Ending May 31, 2022 (Form 10-Q)	28-07-22
Q BIOMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-Q)	28-07-22
Q BioMed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	28-07-22
Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer	26-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Q BioMed Inc.

Aandelen

QBIO

US74736N1054

Andere talen

Filters